India is in a stage of rapid industrialization, with the chemical and pharmaceutical industries playing vital roles. The chemical and pharmaceutical industries have increased tenfold in the last decade wherein the pharmaceutical sector in India is currently worth $50 billion and is anticipated to grow to $65 billion by 2024 and $120 billion by 2030. When it comes to the chemical and pharma sector, it is one of the fastest-growing industries in the country and contributes positively to the national GDP. Moreover, the chemical and pharma industry is a multifaceted industry that affects every sector and industry in the country and is growing every year at an increasing rate. One such company revolutionizing the pharma space is DK Pharmachem.
Founded in 1980 by visionary entrepreneur Dr. Rakesh Bakshi, DK Pharmachem is a renowned manufacturer of APIs, Intermediates, and Specialty Chemicals. DK Pharmachem is known for novel product development as well as for niche molecules, and it currently holds a very strong market position. DK Pharmachem is an ISO 9001 - 2008 certified company with five Multi-Purpose Plans for the production of Multi-Step Advance Intermediates as well as a specialized API Facility with WHO GMP accreditation and PMDA approval.
With such rapid expansion comes the requirement for companies to have solid R&D means. DK Pharmachem R&D is recognized and registered with the Department of Science and Technology, Government of India. New product development as well as Improvisation of existing products is the thrust of its R&D. The firm is staffed with an incredibly strong backend team of Doctors and PhDs who are highly qualified. They oversee research and development and ensure that the products manufactured by DK Pharmachem are of the finest quality. In addition, the company employs around 400 people.
The Vision of Young Entrepreneur Director
DK Pharmachem thru the years has grown multi-fold garnering several prestigious awards and accolades and creating a prominent name for itself in the market, maintaining Consistency, Credibility & Continuity in domestic and global markets for the last 42 years be it product line, relationship with people & CSR activities. Currently, the firm boasts 5 state-of-the-art units and is coming up with another facility within the next few years, increasing its manufacturing capacity by almost threefold. DK Pharmachem takes pride in its unrivaled manufacturing capability,
which allows the firm to supply its products to even the most advanced and big nations. "DK Pharmachem's two API products are ranked first in the world, and three products are in the top three", says DK Pharmachem's Next-Gen Director Karan Bakshi, with full vigor and enthusiasm. The firm is increasing its capacities for current API products with the intent of having every API on its portfolio to be among the top three.
"We specialize in niche molecules, and we choose molecules where there are few manufacturers. If there is a new requirement by the existing customers, our customers know that DK Pharmachem has a strong R&D team that can develop the molecules. That's why they approached us repeatedly", emphasizes Karan Bakshi, Next- Gen Director, DK Pharmachem. Karan Bakshi joined the company in 2009 after completing a master’s degree in advanced chemistry from the UK. Since then, he has been in charge of molecule development, research and development, and scaling up to the plant level. He has developed 5-6 new molecules in the last 10 years and is also developing a few more molecules for growth, which he believes will increase three to fivefold in the next three years.
DK Pharmachem is known for novel product development as well as for niche molecules, & it currently holds a very strong market position
Journey of Excellence & Innovation
DK Pharmachem was founded in 1980 by Dr. Rakesh Bakshi while doing his Master in Chemistry with first class from Bombay University. Currently, he is the steward of governance as a Chairman & Managing Director of DK Group of Companies, DK Pharmachem, DK Biopharma, DK Livkon Healthcare, Sagita, and Ecogreen Industries. Besides, Dr. Bakshi is also playing a positive role in the community and is actively involved in several CSR activities. He has assisted chemical engineers, students from several faculties in their practical vocational training, as well as young entrepreneurs in starting new industrial units, and such 2-3 enterprises have been established with his full support. As part of its social responsibility, DK Pharmachem sponsors a wide range of educational, sports, and cultural programs, including contributions to libraries, laboratories, schools, hospitals, and villages.
Dr. Rakesh Bakshi, chairman of the DK Flag Foundation, has been designated 'Flag Ambassador' by the Flag Foundation of India and is also termed as, 'Flag Man', propagating and bringing awareness about the Indian National Flag and Flag Code. DK Flag foundation has installed Indian National Flag at Ambernath (Hutatma Chowk), Maharashtra 100ft., Raj Bhavan.
Mumbai, Maharashtra 150ft., University of Mumbai, Maharashtra 150ft., Golden Dye Junction Thane (Majiwada), Maharashtra 100ft., Haj House (At highest from Ground level) - Mumbai, Maharashtra 60ft at 350ft. height, SRPF Headquarters Goregaon - Mumbai, Maharashtra 100ft., Collector Office Ratnagiri, Maharashtra 100ft., and many more. DK Flag foundation has also Conducted a Radio Program for 15 days Hamara Tiranga - August 2018, Recorded Jhanda Uncha Rahe Hamara with Asha Bhosle, Usha Mangeshkar, Javed Ali, Sadhana Sargam, and ALL INDIA QUIZ online show on Zoom platform with a run of 18 successful quiz programs - August 2020 Cohosted by famous singer Sharon Prabhakar. “We expand while keeping our future vision open and continue to develop our portfolio in accordance with market specifications.
Now that we see the future in biotech, we are foraying into the biotechnology segment. With our new DK Biotech Plant, we are coming up with one oncology product which will be a single dose, much better in strength than the available medicine in the market. In this endeavor, Tata Institution, a university, as well as the government department will be contributing and supporting us. The product is all set to be a blockbuster wherein we will be pricing it at one-tenth of what is now available in the international market today. All in all, diversification and the addition of new facilities demonstrate our ongoing growth", concludes Dr. Rakesh Bakshi.
.jpg "Artificial Intelligence to Revolutionize Advanced Chip Design")
